Newsroom | 10503 results

BOSTON--(BUSINESS WIRE)--PureTech Founded Entity Seaport Therapeutics Doses First Patient in GlyphAgo Phase 2a Trial in Generalized Anxiety Disorder & Sleep Disturbance...

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Fred Martin has been appointed CEO of health technology company MedSuite, serving the behavioral health market....

LEHI, Utah--(BUSINESS WIRE)--Owlet, Inc. ("Owlet" or the "Company") (NYSE: OWLT), the pioneer of smart infant monitoring, today announces a new partnership with VillageFor, a mental health platform for every path to parenthood and beyond, expanding access to mental health support for new and expecting parents. Founded by two mothers who experienced infertility, NICU stays, and postpartum mental health conditions, VillageFor was built around a simple idea: a mom should not have to be in crisis b...

CHICAGO--(BUSINESS WIRE)--Tempus (NASDAQ: TEM) today announced an expanded, multi-year collaboration to support the potential commercialization of intismeran autogene (V940/mRNA-4157), a novel, potential first-in-class individualized neoantigen therapy (INT) being evaluated in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with completely resected stage IIB-IV melanoma and other cancer types. Intismeran autogene is jointly developed by Moderna and Merck, know...

BOSTON--(BUSINESS WIRE)--Seaport Announces First Patient Dosed in Phase 2a Clinical Trial Evaluating GlyphAgo in Patients with Generalized Anxiety Disorder & Sleep Disturbance...

LOS ANGELES--(BUSINESS WIRE)--SimplePractice, the leading platform powering independent mental health practitioners, and Heard, the financial management platform built for therapists in private practice, today released the 2026 Clinician Well-Being Study. Ahead of World Mental Health Day on October 10, this timely study sheds light on the resilience, challenges, and evolving support systems of independent practitioners. The study, a survey of 862 independent behavioral health practitioners fiel...

MIAMI--(BUSINESS WIRE)--DemeRx, Inc., a clinical-stage biopharmaceutical company dedicated to transforming addiction therapeutics, today announced the appointment of Juan R. Sanchez-Ramos, M.D., Ph.D., to its Scientific Advisory Board. A neurologist and clinician-scientist whose career has spanned addiction, movement disorders, and neurodegenerative diseases, Dr. Sanchez-Ramos was an early leader in the clinical investigation of ibogaine and a scientific collaborator of DemeRx founder and CEO D...

LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)--New Logitech Ctrl Tomorrow Study Reveals Technology’s Impact On Mood, Wellbeing, Performance and Potential...

PARIS--(BUSINESS WIRE)--Wellhub, plateforme mondiale de bien-être en entreprise, annonce aujourd’hui son lancement officiel en France. Déjà présente dans 19 pays et utilisée par plus de 50 000 entreprises dans le monde, Wellhub souhaite accompagner les employeurs français dans l’évolution de leur promesse employeur, alors que le bien-être prend une place croissante dans les attentes des salariés et les stratégies RH. Santé mentale, sédentarité, absentéisme, qualité de vie et conditions de trava...

PARIS--(BUSINESS WIRE)--Wellhub, a world’s largest corporate wellness platform, today announces its official launch in France. Already operating in 19 countries and used by more than 50,000 companies worldwide, Wellhub is bringing its approach to the French market as wellbeing plays an increasingly important role in employee expectations, HR strategies and the overall employee value proposition. Mental wellbeing, sedentary lifestyles, absenteeism, quality of working life and working conditions...